close
MENU
Hot Topic Budget 25
How to guide
How to guide
Home
NBR Marketplace
The NBR List
NBR Video

Categories

General Business Investment Economics Te Ao Māori Politics Infrastructure Australia Tech & Innovation Finance Law Professional Services Primary Industries Retail Property Deals Marketing & Media Tourism Energy Luxury Property Aviation News Comings & Goings

Analysis

All Economy Matters Edwards on Politics Hunter’s Corner Last Word Margin Call On the Money Shoeshine Underarm NBR Focus

Featured

The NBR Podcast Morning Brew The Grind Entrepreneurs Your Business Beehive Banter Toil & Trouble Market Outlook Dollars & Sense Local Edge Private Bin Audio Articles Podcasts NZ Aviation News Back Issues NBR Radar (Archive) Opinion (Archive) NBR Rich List (Archive)
Hot Topic Budget 25
Tech & Innovation
2 mins to read

Fisher & Paykel Healthcare updates guidance on strong performance

The respiratory healthcare company is firing on all cylinders.

FPH managing director and CEO Lewis Gradon.

Fiona Rotherham Fri, 23 Aug 2024

Listed respiratory healthcare company Fisher & Paykel Healthcare has provided guidance on the first half of the 2025 financial year after a strong year to date across all products and regions.

It has forecast an 18% lift in revenue of between $940 million to $950m for the first half of the 2025

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
View terms and conditions.
Individual
Group membership
NBR Marketplace

Smartphone Only Subscription

NZ$29.95 / monthly

Monthly Premium Online Subscription

NZ$49.95 / monthly

Smartphone Only Annual Subscription

NZ$299.00 / yearly

Yearly Premium Online Subscription

NZ$499.00 / yearly

Premium Group Membership 10 Users

NZ$385+GST / monthly

$38.5 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$660+GST / monthly

$33 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1375+GST / monthly

$27.5 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$2100+GST / monthly

$21 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$999.00 / yearly

Already have an account? Login
Fiona Rotherham Fri, 23 Aug 2024
Contact the Writer: fiona@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Tags
Fisher & Paykel Healthcare Lewis Gradon
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low

Free News Alerts

Sign up to get the latest stories and insights delivered to your inbox – free, every day.

I’m already subscribed/joined
Related News
Comings & Goings

Mark Cross appointed to FPH board
Investment

Fisher & Paykel Healthcare returns to pre-Covid growth trajectory
Investment

F&P Healthcare initiates $12m voluntary recall of Airvo devices
Investment

Unusual times ‘still ankle tapping us’: FPH boss

Free News Alerts

Sign up to get the latest stories and insights delivered to your inbox – free, every day.

I’m already subscribed/joined
Company profile
Powered by: nzx logo
Change:
Price
Previous Close
Turnover
Movement
Volume
Avg Daily Volume
Daily High
Daily Low
52 Week High
52 Week Low
Related News
Comings & Goings

Mark Cross appointed to FPH board
Investment

Fisher & Paykel Healthcare returns to pre-Covid growth trajectory
Investment

F&P Healthcare initiates $12m voluntary recall of Airvo devices
Investment

Unusual times ‘still ankle tapping us’: FPH boss
Fisher & Paykel Healthcare updates guidance on strong performance
Tech & Innovation,
105490
true
Subscribe Login